MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA

Stock Information for Medipharm Labs Corp

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Medipharm Labs Corp

MediPharm Labs Appoints Greg Hunter as Chief Executive Officer and Director
MediPharm Labs Expands Its International Medical Cannabis Footprint with First CBD Metered-Dose Inhaler Shipment to Panama
MediPharm Labs Reports Positive Q2 2026 Net Income and Second Consecutive Quarter of Positive Adjusted EBITDA
MediPharm Labs Sets Date to Report Second Quarter 2026 Financial Results
MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer's Disease and Dementia
MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders
MediPharm Labs Reminds Shareholders of Upcoming Annual and Special Meeting
MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.